Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Receivables - Net (2018 - 2025)

AVITA Medical filings provide 8 years of Receivables - Net readings, the most recent being $9.1 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 22.91% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.1 million, a 22.91% decrease, with the full-year FY2025 number at $9.1 million, down 22.91% from a year prior.
  • Receivables - Net hit $9.1 million in Q4 2025 for AVITA Medical, up from $9.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $12.0 million in Q1 2025 to a low of $2.2 million in Q1 2021.
  • Median Receivables - Net over the past 5 years was $5.8 million (2023), compared with a mean of $6.5 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 118.04% in 2023 and later dropped 22.91% in 2025.
  • AVITA Medical's Receivables - Net stood at $3.1 million in 2021, then grew by 12.73% to $3.5 million in 2022, then surged by 118.04% to $7.7 million in 2023, then skyrocketed by 53.78% to $11.8 million in 2024, then dropped by 22.91% to $9.1 million in 2025.
  • The last three reported values for Receivables - Net were $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025) per Business Quant data.